key: cord-0855524-m2j3ncl4
authors: Nuño, Miriam; García, Yury; Rajasekar, Ganesh; Pinheiro, Diego; Schmidt, Alec J.
title: COVID-19 hospitalizations in five California hospitals: a retrospective cohort study
date: 2021-09-10
journal: BMC Infect Dis
DOI: 10.1186/s12879-021-06640-4
sha: 79a293b5efb8d6ffe36851eea7ce28c710c61499
doc_id: 855524
cord_uid: m2j3ncl4

BACKGROUND: The novel coronavirus pandemic has had a differential impact on communities of color across the US. The University of California hospital system serves a large population of people who are often underrepresented elsewhere. Data from hospital stays can provide much-needed localized information on risk factors for severe cases and/or death. METHODS: Patient-level retrospective case series of laboratory-confirmed COVID-19 hospital admissions at five UC hospitals (N = 4730). Odds ratios of ICU admission, death, and a composite of both outcomes were calculated with univariate and multivariate logistic regression based on patient characteristics, including sex, race/ethnicity, and select comorbidities. Associations between comorbidities were quantified and visualized with a correlation network. RESULTS: Overall mortality rate was 7.0% (329/4,730). ICU mortality rate was 18.8% (225/1,194). The rate of the composite outcome (ICU admission and/or death) was 27.4% (1298/4730). Comorbidity-controlled odds of a composite outcome were increased for age 75–84 (OR 1.47, 95% CI 1.11–1.93) and 85–59 (OR 1.39, 95% CI 1.04–1.87) compared to 18–34 year-olds, males (OR 1.39, 95% CI 1.21–1.59) vs. females, and patients identifying as Hispanic/Latino (OR 1.35, 95% CI 1.14–1.61) or Asian (OR 1.43, 95% CI 1.23–1.82) compared to White. Patients with 5 or more comorbidities were exceedingly likely to experience a composite outcome (OR 2.74, 95% CI 2.32–3.25). CONCLUSIONS: Males, older patients, those with multiple pre-existing comorbidities, and those identifying as Hispanic/Latino or Asian experienced an increased risk of ICU admission and/or death. These results are consistent with reported risks among the Hispanic/Latino population elsewhere in the United States, and confirm multiple concerns about heightened risk among the Asian population in California. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06640-4.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (COVID-19) has been a devastating pandemic, with over 91 million confirmed cases and nearly 2 million deaths worldwide [1] . In the United States, the state of California (hereafter referred to as CA) leads the charts for the worse surge across the nation, with a total of 70,561 confirmed cases per million residents, 1176 confirmed deaths per million residents, and potentially 1173 ICU beds available for a population of nearly 40 million (January 12, 2021).

Advanced age, chronic underlying conditions (including hypertension, diabetes, chronic kidney disease, among others), and being male are associated with an increased risk of hospitalization and death from COVID-19 [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . There is additional, mounting evidence that some racial and ethnic minority groups are at disproportionate risk [3, 5, 6, 11] . Nation-wide, the Black/African Open Access *Correspondence: mnuno@ucdavis.edu 1 Department of Public Health Sciences, University of California, One Shields Avenue, Medical Sciences 1C, Davis, CA 95616, USA Full list of author information is available at the end of the article American, Hispanic/Latino, Asian, and American Indian/ Alaskan Native (AIAN) populations have seen elevated crude rates of infection, hospitalization, and/or mortality compared to the White population [15] . In trends similar to other states, estimates from CA indicate that the Hispanic/Latino population make up 55% of confirmed cases and 47% of deaths and only 39% of the total population the Black/African American population represent 4% of confirmed cases and 7% of deaths and only 6% of the total population; and the Asian population represent 7% of all cases but 12% of all deaths. Multiple informal analyses report that Asians have low rates 7of confirmed cases but concerningly high case fatality rates [16] , but few studies have been large enough to capture associated risk factors in this population.

More diverse, localized information is needed about who is being hospitalized with COVID-19 and their outcomes in the United States, and California in particular, especially since the second surge in the last half of 2020. This study describes the demographic characteristics, baseline comorbidities, and outcomes of patients hospitalized with COVID-19 in five acute care medical centers in the University of California Health System.

In this retrospective cohort study, we identified patients who were hospitalized with laboratory-confirmed SARS-CoV-2 infections at any of the five UC Health hospitals between December 13, 2019 and January 6, 2021 by extracting electronic medical records (EMRs) from The COVID Research Data Set (CORDS). The index date corresponds to the first confirmed COVID-19 diagnosis. A hospitalization was included if test confirmation occurred within 21 days or during an inpatient admission. SARS-CoV-2 positive status was determined by PCR or SNOMED code 840539006 (Disease caused by Severe acute respiratory syndrome coronavirus 2) during their earliest hospitalization (Additional file 1: Table S1 ).

Patient characteristics, including race/ethnicity, sex, comorbidities, and clinical outcomes were collected. Data was queried on January 8, 2021 and tabulated by January 10, 2021. We captured comorbidities using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) classification (Additional file 1: Table S2 ). Self-identified race/ethnicity was categorized into White, Hispanic/Latino, Black/ African American, and Asian; Other includes AIAN (n = 9, 0.19%), Native Hawaiian or Other Pacific Islander (n = 53, 1.12%), Other (n = 169, 3.57%), Unknown (n = 246, 5.20%), and those that identified with multiple race/ethnicity (n = 46, 0.97%).

Comorbidities included cancer, cardiac disease, cerebrovascular disease, coagulopathy, deficiency anemia, depression, diabetes, drug use disorders, HIV/Aids, hypertension, hypothyroidism, liver disease, neurological conditions, obesity, paralysis, pregnancy, psychoses, pulmonary disease, renal failure, collagen vascular disease, smoking status, and solid organ transplantation. Comorbidities documented 2 months prior to COVID-19 confirmation, during hospitalization, or 2 months post discharge were considered. The 2 month post-discharge observation period to capture comorbidities was deemed reasonable given lags in data entry due to billing. A comorbidity score represented the sum of any of these conditions. The lowest score of a 0 (n = 1806, 38.2%) was assigned to patients without documented comorbidities. The co-occurrence of comorbidities was illustrated through correlation networks. The UC Davis implementation of the University of California COVID Research Data Set (CORDS) was determined exempt from human subject protection under IRB protocol 1604619-1. Informed Consent was not deemed necessary for deidentified data by Nicholas and Kent Anderson at the UC Davis Clinical and Translational Science Award (CTSC) Biomedical Informatics Program.

Univariate logistic regression was used to calculate the crude odds ratio (OR) of ICU admission and mortality events to discharge from the hospital. Multivariable logistic regression was used to estimate the odd ratio of the composite outcome of ICU admission and/or death during hospitalization to discharge from the hospital. The multivariable model adjusted for age in years at admission, sex, and race/ethnicity. Odds ratios and 95% confidence intervals (95% CI) were reported.

We measured the strength of comorbidity associations with the Pearson's correlation coefficient (� ) for binary variables. The correlation coefficient between a pair of comorbidities, ij , was calculated according to Equation

where Cij corresponds to the number of patients affected by both comorbidities, N is the total number of patients in the study, and Pi is the prevalence of the ith comorbidity. The distribution of values represent all disease pairs where Cij > 0. The correlation for the dichotomous variable is denoted by and a t-test is used to determine the significance of ≠ 0 [17] .

We visualized comorbidities with correlation ( > 0) larger than expected by chance for the entire cohort, as well as stratified by composite outcome.

We described patterns in cumulative hospitalizations during the study period over time by using change-point analysis to discern specific time points where abrupt changes in the mean occurred. This algorithm detects multiple points of change in time-ordered data through binary segmentation [18] [19] [20] . First, we applied a changepoint statistical test to the entire time series of hospitalization cases. Then, we split the series into two new ones when a point change was found. We repeated this procedure several times until there were no further significant change points. Statistical analyses were conducted using SAS software, version 9.4 (SAS Institute, Cary, NC, USA), the changepoint package (binary segmentation algorithm) in R version 4.0.1 (R Core Team 2020), and Python. Data were analyzed from January 8 to January 20, 2021.

A total of 4,730 hospitalized patients with positive SARS-CoV-2 assays were included (median age 61 years, IQR: 46-73) ( Table 1) . 56.4% were male; one patient was missing sex data. A total of 339 (7.2%) identified as Black/ African American, 2161 (45.7%) as Hispanic/Latino, 489 (10.3%) as Asian, 523 (11.1%) were documented as Other/Unknown, and 1218 (25.8%) identified as White. A moderate fraction of patients did not have documented comorbidities (n = 1806, 38.2%). The most common comorbidities were hypertension (35.2%), cardiac disease (33.3%), diabetes (24.0%), pulmonary disease (17.8%), obesity (17.3%), and renal failure (15.3%). Coagulopathy (11.8%), smoking (10.2%), depression (9.4%), liver disease (8.8%), and cerebrovascular disease (7.8%) were also reported. Among the possible 22 comorbidities documented for each individual patient, we found that 457 (9.7%) patients had one, 488 (10.2%) had two, 468 (9.9%) had three, 430 (9.1%) had four, 355 (7.5%) had five, and 726 (15.4%) had six or more comorbidities.

We quantified the network of comorbidities and visualized correlations that were positive and significant by linking chronic conditions in a visual network (Fig. 1) . Figure 1A displays correlations across the total cohort, of which hypertension and heart disease showed the strongest correlation; Fig. 1B displays the correlation network among patients that did not experience a composite outcome; and Fig. 1C describes the correlation network of comorbidities for patients that experienced a composite outcome. Figure 1B and C together suggest that hypertension, diabetes, cardiac disease, renal failure, neurological disease, and depression, among other diseases, tend to be more comorbid in individuals that experienced a composite outcome than in those that did not. The comorbidity network structure in Fig. 1A summarized and reflected well-known associations with COVID-19 hospitalizations, while suggesting that the interactions between comorbidities are expressed differently in those with more severe and deadly cases. 

We identified 1194 (25.2%) patients who were admitted to the intensive care unit with confirmed infection with SARS-CoV-2 (Table 1 ). In unadjusted univariate analyses, patients of age 55-74 and 75-84 years were more likely to be admitted to the ICU than 18-44 year-olds, and ICU admission was more likely in male patients than female. Hispanic/Latino, Black/African American, and Asian patients were no more or less likely to be admitted to the ICU once in the hospital than White patients, though Other races/ethnicities were (OR 1.36, 95% CI 1.08-1.71). Among the common comorbidities, the most likely to be admitted to the ICU were those patients with neurological conditions ( (Fig. 4) . Patients with higher number of comorbidities were also more likely to experience a composite outcome (≥ 5 vs. none, OR 1.74, 95% CI 2.32-3.25).

In this study of 4730 patients with COVID-19 requiring hospitalization at five hospitals in California, 25.2% were admitted to the ICU, and 7.0% died. Patients were older (20% greater than 75 years), largely Hispanic/Latino (45.7%), with moderate representation of White (25.8%), Asian (10.3%), and Black/African American (7.2%). The 1-year cumulative ICU admission rate for COVID-19 is equitable to previous reports, but the in-hospital mortality rate is smaller than observed in case studies from earlier in course of the pandemic: ICU admission rates ranged from 14.2% to 35.7% in March-May 2020, where mortality rates ranged from 21.0% to 29.1% over the same period [2, 9, 11, 21] . Our study captured the experience of patients hospitalized for COVID-19 in five hospitals in California, across which the rates of composite outcome ranged from 18.2% to 34.2%. The variability of this outcome by hospital is likely influenced by differences in patient severity and treatment practices for COVID-19 across hospital settings, which have evolved throughout 2020, and regional fluctuations in the scope of the pandemic. Differences observed in mortality and severity of COVID-19 among patients that require hospitalization are probably multifactorial. Our sample was drawn from a longer time period, which would include effects from improved treatment options and resource availability that were frequently lacking during earlier stages. Additionally, geographic differences in the distribution of races/ethnicities and the prevalence of chronic conditions that appear to increase the risk of severe illness may contribute to differences in hospital outcomes across the country. Criteria for hospital admission may have changed throughout this pandemic and likely will be driven, at least partially, by the availability of resources and ICU beds, which have fluctuated as well. Despite the documented differences in the outcomes of hospitalized COVID-19 patients, trends in these outcomes across the five hospitals during the study period are consistent, with reasonable fluctuations of the outcomes assessed.

The associations with older age, comorbidities, and race/ethnicity with poor outcomes linked to COVID-19 hospitalization are largely consistent with previous findings. This study also highlighted the increased risk of poor outcomes in the Asian population of California. In most states and counties, the relatively small proportion of Asian in the population makes awareness of cases and deaths in this community more challenging, as general samples large enough to make conclusions from are difficult to come by. California is one of few states with a sufficiently sizable Asian population for their COVID-19 burden to become unmistakable in the aggregate. There is growing recognition of the burden of COVID-19 among Asian, but data on outcomes among Asian ethnic subgroups remain extremely limited. A recent systematic review and meta-analysis of 50 studies from the US and United Kingdom found higher risk of COVID-19 infection among Asians and Blacks compared to Whites, and possibly an increased risk of ICU admission and death only among Asians compared to Whites [22] . Further studies are needed to investigate the impact of COVID-19 infection and severity in Asian populations, particularly addressing potential differences in Asian ethnic subgroups at a broader geographic scale. These investigations will be critical to appropriately allocate resources to hardest hit communities, including testing and communication regarding seeking care as well as public health policies to mitigate risk factors and improve health equity.

The composite outcome in this study involved an ICU admission and/or in-hospital mortality, which occurred in 27.5% of patients. We reported rates only for patients who were discharged alive or died during the hospitalization by the end of the study period. 61.8% of patients had 1 or more relevant comorbidities and nearly 23% had 5 or more of these pre-existing conditions, which substantially increased the odds of a poor outcome. Using a network-based approach, we found that hypertension, cardiac disease, diabetes, and renal failure are positively and significantly associated to each other in the overall population, a relationship even more evident in patients with a composite outcome.

This study has several limitations. Our findings represent the experience of five hospitals within the UC Health system and therefore may have limited external generalizability to other health care settings, especially outside of California. Since our sample was drawn from electronic medical records and not full chart reviews, our data was also missing reported symptoms and the patients' stated reasons for seeking COVID-19 tests, which could be one or a combination of the presence of COVID-19 symptoms, notification of exposure through contact tracing, or seeking a test in lieu of observing a 14-day quarantine period after travel. Since our analysis was based on ICU admission, death, or discharge over the course of a single hospital stay, no losses to follow-up were represented in our data. Such a large cohort followed over an extended time of period will necessarily include aggregation biases due to differential test availability, hospital admission practices, and documentation across the five medical centers, especially as public health advice evolved over the observation period. This could very well have obscured evolving demographic trends as the pandemic developed, or introduced a confounding bias in crude measures. Finally, this study does not address or account for the possibility of patients dying elsewhere. Cases who were tested at UC Health and sought care outside the system were not captured in this database, meaning any subsequent hospitalizations, ICU admissions, or mortality events of positive, confirmed cases outside the UC Health system would not have been captured either. Notwithstanding these limitations, this study provides comparative epidemiologic characteristics of a diverse and underrepresented population of patients admitted to the hospital with COVID-19 over an entire year of the pandemic. Particularly relevant is the captured experience of Asians hospitalized due to COVID-19, and the differences in demographic characteristics and associations of comorbidities with each other and with poor outcomes.

In this study, we found that older patients, with multiple comorbidities, identifying as Hispanic/Latino or Asian were more likely to be admitted to the intensive care unit and/or die during hospitalization at five UC Health medical centers. The overall mortality rate observed is significantly lower than what has been documented in hospitalized patients with COVID-19 from the early stages of the pandemic, despite the reported high levels of comorbidities. These findings provide additional evidence of the impact of COVID-19 in system of hospitals in California. While the comparatively low mortality rate is reassuring, the differential impact on racial/Ethnic minorities requires the implementation of an equitable solution.

COVID-19 Dashboard

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

Risk factors for coronavirus disease 2019 (COVID-19)-associated hospitalization: COVID-19-associated hospitalization surveillance network and behavioral risk factor surveillance system

Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy

Risk factors associated with in-hospital mortality in a US National sample of patients with COVID-19

Natural history of COVID-19: risk factors for hospitalizations and deaths among >26 million U.S. Medicare beneficiaries

The risk factors for the exacerbation of COVID-19 disease: a case-control study

Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 -COVID-NET, 14 States

Risk factors for in-hospital mortality from COVID-19 infection among black patients-an urban center experience

Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score

Association of race and ethnicity with comorbidities and survival among patients with COVID-19 at an urban medical center in New York

Overweight, obesity, and risk of hospitalization for COVID-19: a community-based cohort study of adults in the United Kingdom

CoVA: an acuity score for outpatient screening that predicts coronavirus disease 2019 prognosis

Predictors for severe COVID-19 infection

COVID-19): cases in the US

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

A dynamic network approach for the study of human phenotypes

A method for cluster analysis

A cluster analysis method for grouping means in the analysis of variance

On tests for detecting change in mean

Hospitalization and mortality among black patients and white patients with Covid-19

Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Dr. Nuño wish to thank Dr. James M. Bugni and Blanca Nuño for supporting this research effort and providing critical feedback to improve this study. We additionally wish to thank members of the IT Health Informatics division at UC Davis. Hemanth Tatiparthi and Ranjit Singh created the local CORDS database, Steve Covington provided advice about querying the database, and Brian Paciotti helped evaluate data irregularities among sites. 1 

The online version contains supplementary material available at https:// doi. org/ 10. 1186/ s12879-021-06640-4. Additional file 1: Table S1 . Severe acute respiratory syndrome coronavirus 2 Lab Tests. Table S2 . International classification of disease codes for comoridities. Appendix S1. Correlation Network of comorbidities. Appendix S2. Change-point detection analysis of hospitalizations, ICU admissions, and In-Hospital deaths. Figure S1 . Fits of data and change points. 

The authors declare that they have no competing interests.